Weller, Michael (2018). Where does O -methylguanine DNA methyltransferase promoter methylation assessment place temozolomide in the future standards of care for glioblastoma? Cancer, 124(7):1316-1318.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
| Item Type: | Journal Article, refereed, further contribution |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Oncology
Life Sciences > Cancer Research |
| Language: | English |
| Date: | 1 April 2018 |
| Deposited On: | 24 Oct 2018 15:48 |
| Last Modified: | 28 Nov 2023 08:00 |
| Publisher: | Wiley-Blackwell Publishing, Inc. |
| ISSN: | 0008-543X |
| OA Status: | Closed |
| Free access at: | Publisher DOI. An embargo period may apply. |
| Publisher DOI: | https://doi.org/10.1002/cncr.31244 |
| PubMed ID: | 29381186 |
Weller, Michael